EFFICIENCY, SAFETY AND UNWARRANTED POLYPHARMACY IN THE TREATMENT OF ACUTE RESPIRATORY DISEASES
Issue:
11
Year:
2016
In certain seasons, the population and clinicians traditionally show an increasing interest in the use of anti-influenza or cold remedies, mainly antiviral, immunotropic, and symptomatic agents. The abundance of these medications, most of them over-the-counter ones, hinders their right choice.
Keywords:
infectious diseases
acute respiratory viral infections
influenza
prevention
safety
References:
- The world health report 2002 – Reducing Risks, Promoting Healthy Life // World Health Organization. – 2002; 186: 192.
- Rothberg M., Haessler S., Brown R. Complications of viral influenza // Am. J. Med. – 2008; 121 (4): 258–64.
- Dvoretskij L.I. Lechenie bol'nyh ostrymi respiratornymi zabolevanijami: est' li al'ternativa polipragmazii? // Consillium Medicum. – 2008; 10 (10): 10–4.
- Kljuchnikov S.O. Polipragmazija: puti reshenija problemy // Detskie infektsii. – 2014; 4: 36–41.
- Jefferson T., Jones M., Doshi P. et al. Neuraminidase inhibitors for preventing and treating influenza in adults and children // Cochrane Database Syst. Rev. – 2014; 4: CD008965. DOI: 10.1002/14651858.CD008965.pub4.
- Jefferson T., Jones M., Doshi P. et al. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments // BMJ. – 2014; 348: g2545. doi: http://dx.doi.org/10.1136/bmj.g2545 (Published 09 April 2014)
- http://www.whocc.no/atc_ddd_index/code=J05AX
- Leneva I.A., Fedjakina I.T., Eropkin M.Ju. i dr. Izuchenie protivovirusnoj aktivnosti otechestvennyh protivogrippoznyh himiopreparatov v kul'ture kletok i na modeli zhivotnyh // Vopr. virusol. – 2010; 3:19–25.
- Lombardo F., Waters N., Argikar U. et al. Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance // J. Clin. Pharmacol. – 2013; 53 (2): 178–91.
- Berry L., Li C., Zhao Z. Species differences in distribution and prediction of human V(ss) from preclinical data // Drug Metab. Dispos. – 2011; 39 (11): 2103–16.
- Kolobukhina L., Merkulova L., Shchelkanov M. et al. Efficacy of ingavirin in adults with influenza // Ter. Arkh. – 2009; 81 (3): 51–4.
- Svistushkin V.M., Nikiforova G.N., Vlasova N.P. Vozmozhnosti lechenija bol'nyh s ostrymi respiratornymi virusnymi infektsijami v nastojaschee vremja // Lechaschij vrach. – 2013; 1: 2–5.
- Haria M., Benfield P. Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis // Drugs. – 1995; 50 (5): 873–96.
- Sbornik nauchnyh statej po osnovam gomeopatii i gomeopaticheskim preparatam / M., 2001.
- Gomeopatija v XXI veke: vozmozhnosti i perspektivy // Meditsinskij sovet. – 2016; 16: 38–42.
- Marrari L., Terzan L., Chaufferin G. Oscillococcinum for influenza treatment // Ann. Ist. Super Sanita. – 2012; 48 (1): 105–9.
- Beghi G., Morselli-Labate A. Does homeopathic medicine have a preventive effect on respiratory tract infections? A real life observational study // Multidiscip. Respir. Med. – 2016; 11: 12.
- 18. Mathie R., Frye J., Fisher P. Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness // Cochrane Database Syst. Rev. – 2015; 1: CD001957.
- Kovalenko L.P., Tollerova A.V., Kuzntsova O.S. i dr. Eksperimental'noe izuchenie allergizirujuschih svojstv i immunotoksichnosti preparata Otsillokoktsinum // Toksikol. vestn. – 2015; 1 (130): 37–41.
- Sel'kova E.P., Volchetskij A.L., Lapitskaja A.S. i dr. Vlijanie Otsillokotsinuma na interferon obrazovanie u chasto bolejuschih detej // Consilium Medicum. Pediatrija. – 2009; 4: 42–7.
- Egorov V.I., Kozarenko A.V. Sovremennyj podhod k lecheniju ostryh virusnyh rinosinusitov // Al'manah klinicheskoj meditsiny. – 2016; 44 (7).
- Geppe N.A., Krylova N.A., Tjurina E.N. i dr. Napravlenie sovershenstvovanija terapii ORVI u detej // Doktor.Ru. – 2016; 6 (123): 47–51.
- Samsygina G.A. i dr. Novye tehnologii v profilaktike ostryh respiratornyh infektsij i grippa u detej mladshego vozrasta // Pediatrija. – 2008; 5 (87).
- Sel'kova E.P., Lapitskaja A.C., Oganesjan A.S. i dr. Izuchenie kliniko-epidemiologicheskoj effektivnosti gomeopaticheskogo preparata pri grippe i ORVI // Infekts. bolezni. – 2012; 10 (3): 83–9.
- Papp P., Shubak P., Bek E. et al. // Britich Homoeopathik Journal. – 1998; 87: 69–76.
- Kazjukova T.V., Radtsig E.Ju., Pankratov I.V. i dr. Sravnitel'naja otsenka effektivnosti dvuh protivovirusnyh preparatov v lechenii grippa i ORVI u detej 6–12 let // Pediatrija. – 2015; 6: 105–12.